(+34) 951 419 212
DONORS
Donors at Ovobank are women between 18 and 32 years of age, and our male donors are between 18 and 35, all in good physical and psychological health. They undergo thorough gynecological, serological, and genetic examinations. Only 34% of donor applicants are ultimately declared eligible after these tests, while 73% are excluded for medical reasons (due to family histories of conditions such as epilepsy or thalassemia, among others).
Genetic matching
Genetic Test Compatibility or Genetic Matching compares the genetic information of the donor and the partner of the recipient woman in order to reduce the transmission of autosomal recessive genetic diseases. This information will be compared when selecting the suitable donor, in such a way that patient and donor do not share mutations in the same gene.
Legislation
Ovobank operates in accordance with applicable legislation and quality standards in each country, ensuring regulatory compliance, traceability, and safety in the management of human tissues and cells.
Donation
The donation process is performed in our clinics to ensure safety. Expert lab staff manage the treatment and vitrification of oocytes to maintain high standards.
Treatment
Comprehensive guidance is offered to donors throughout the process. Medication is adjusted based on hormonal studies, BMI, and other individual characteristics.
Exclusion criteria
Only 34% of candidates are accepted due to comprehensive screening, ensuring only the most suitable donors are selected for our program.
Initial evaluation
Potential donors undergo initial assessments, including a review of personal history, psychological status, and health conditions.
Medical check-up
A medical check-up by our specialised team includes a hormonal study, complete gynaecological exam, blood work, and serology analysis for safety.
Genetic testing
Since 2016, Ovobank has implemented the Genetic Matching Test to reduce transmission of genetic diseases in children born from donor eggs.
Blood tests
Essential blood tests include pathological anatomy, haemogram, biochemistry, serology, real-time tests, and comprehensive genetic analyses.
Psychological study
An in-depth interview and psychological study are conducted by specialists to detect any disorders or habits that may pose risks.
GENETIC STUDIES
In our ongoing effort to optimize the safety level of our donated oocytes, since December 1, 2016, we have conducted carrier screening for recessive mutations*(Genetic Compatibility Testing) on new donors to minimize the transmission of genetic diseases to children born from donated eggs.
THANKS TO THESE TESTS:
We can exclude from the egg donation program candidates who are carriers of any of the autosomal recessive mutations studied in the panel, corresponding to the following diseases:
Cystic
Fibrosis
Spinal
Muscular Atrophy
Alpha
Thalassemia
Beta
Thalassemia
X-linked diseases
(Fragile X or G6PD, among others)
Non-syndromic deafness
(donors screened up to October 1, 2019)